WILLIAM JL RIEFLIN Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for WILLIAM JL RIEFLIN.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of WILLIAM JL RIEFLIN. WILLIAM JL RIEFLIN is a Exec VP, Admin & Gen. Counsel in TULARIK INC ($TLRK) and a Director in XENOPORT INC ($XNPT) and a Director in Anacor Pharmaceuticals, Inc. ($ANAC) and an Executive Chairman in NGM BIOPHARMACEUTICALS INC ($NGM) and a in RAPT Therapeutics, Inc. ($RAPT) and a Director in RAPT Therapeutics, Inc. ($RAPT).
Address: C/O TULARIK INC. 1120 VETERANS BLVD. SO. SAN FRANCISCO 94080 CA
Companies in which WILLIAM JL RIEFLIN is an Insider
Anacor Pharmaceuticals, Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of WILLIAM JL RIEFLIN: Director
Holdings: 0 shares
Latest Transaction: Jun 24 2016
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
NGM BIOPHARMACEUTICALS INC
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of WILLIAM JL RIEFLIN: Executive Chairman
Holdings: 2,769,168 shares
Latest Transaction: Mar 18 2021
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
RAPT Therapeutics, Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of WILLIAM JL RIEFLIN:
Holdings: 18,000 shares
Latest Transaction: Jun 24 2021
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
TULARIK INC
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of WILLIAM JL RIEFLIN: Exec VP, Admin & Gen. Counsel
Holdings: 0 shares
Latest Transaction: Aug 17 2004
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
XENOPORT INC
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of WILLIAM JL RIEFLIN: Director
Holdings: 0 shares
Latest Transaction: Jul 06 2016
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Latest Insider Trading Transactions of WILLIAM JL RIEFLIN
Sentiment: All, ANAC, NGM, RAPT, TLRK, XNPT
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jun 24 2021 | RAPT | RAPT Therapeutics, ... | RIEFLIN WILLIAM JL | Option Exercise | A | 19.30 | 7,500 | 144,750 | 7,500 | ||
| Mar 18 2021 | NGM | NGM BIOPHARMACEUTI ... | RIEFLIN WILLIAM JL | Executive Chairman | Option Exercise | A | 31.93 | 80,000 | 2,554,400 | 80,000 | |
| Nov 20 2020 | RAPT | RAPT Therapeutics, ... | RIEFLIN WILLIAM JL | Buy | P | 16.22 | 10,000 | 162,200 | 18,000 | 8 K to 18 K (+125.00 %) | |
| Jun 19 2020 | RAPT | RAPT Therapeutics, ... | RIEFLIN WILLIAM JL | Director | Option Exercise | A | 28.27 | 7,500 | 212,025 | 7,500 | |
| Feb 06 2020 | NGM | NGM BIOPHARMACEUTI ... | RIEFLIN WILLIAM JL | Executive Chairman | Option Exercise | A | 16.47 | 75,000 | 1,235,250 | 75,000 | |
| Nov 04 2019 | RAPT | RAPT Therapeutics, ... | RIEFLIN WILLIAM JL | Director | Option Exercise | C | 0.00 | 100,000 | 0 | 0 | |
| Nov 04 2019 | RAPT | RAPT Therapeutics, ... | RIEFLIN WILLIAM JL | Director | Option Exercise | C | 0.00 | 260,344 | 0 | 0 |